glp-1 kidney disease news Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists Real-World Evidence for GLP-1 Receptor
Description
[4] Has not been studied in combination with insulin
In type-2 diabetic models (genetically-inherited or diet-induced obesity), exenatide significantly enhances bone strength by increasing trabecular bone mass, bone formation and trabecular microarchitecture
Data were normalized to maximum concentrations of GLP-1 or GIP (100%) and no ligand (0%) and analyzed by nonlinear regression (sigmoidal concentration-response) and plotted using GraphPad Prism 7 software
Since Ozempic supports weight loss, it could lower your long-term flare risk
